Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 2316-64-5 | MDL No. : | MFCD00004618 |
Formula : | C7H7BrO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KNKRHSVKIORZQB-UHFFFAOYSA-N |
M.W : | 203.03 | Pubchem ID : | 75342 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.14 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 42.29 |
TPSA : | 40.46 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -6.32 cm/s |
Log Po/w (iLOGP) : | 1.75 |
Log Po/w (XLOGP3) : | 1.72 |
Log Po/w (WLOGP) : | 1.5 |
Log Po/w (MLOGP) : | 1.64 |
Log Po/w (SILICOS-IT) : | 1.87 |
Consensus Log Po/w : | 1.7 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.56 |
Solubility : | 0.559 mg/ml ; 0.00275 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.19 |
Solubility : | 1.32 mg/ml ; 0.00652 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.51 |
Solubility : | 0.627 mg/ml ; 0.00309 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.22 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
84% | With sodium tetrahydroborate In ethanol at 0 - 20℃; for 18 h; Schlenk technique; Inert atmosphere | The compound was prepared according to the literature using a modified synthetic procedure: 5-bromo-2-hydroxybenzaldehyde (10.1 g, 50 mmol) was dissolved in 250 mL of ethanol at 0 °C. NaBH4 (1.88 g, 50 mmol) was added in portions ( 0.3 g) to the stirred solution. The mixture was stirred at room temperature for 18 h. After removal of ethanol under reduced pressure (10 2 mbar) the resulting pale yellow solid was dissolved in 200 mL of a saturated, aqueous NH4Cl solution. The crude product was extracted with diethyl ether (three times 80 mL). The organic phase was washed with brine (three times 20 mL) and dried with MgSO4 for 2 h. After removal of MgSO4 by filtration and excess solvent under reduced pressure (10 2 mbar) the product was purified by flash chromatography with silica (eluent: n-hexane/ethyl acetate – volume ratio of 8/2) to give a colorless solid after evaporation of the solvent (8.52 g, 84percent); |
150 g | at 0 - 20℃; for 5 h; | 5L three bottles, Compound 1 -7 (154 g, 0.766 mol 1) was dissolved in ethanol (3 L) 0 ° C Under conditions, sodium borohydride (298, 0.762 mol) was slowly added, Stirred at room temperature for 5 hours. The reaction solution was added with hydrochloric acid to adjust the pH to 2 to 3, Control temperature below 10 ° C; Ethyl acetate (500 mL) The organic phase was washed with saturated brine (500 mL) Sodium sulfate, filter, Concentration gave 150 g of a gray solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
60% | Stage #1: With lithium aluminium tetrahydride In tetrahydrofuran at 20℃; for 16 h; Stage #2: With hydrogenchloride In tetrahydrofuran; water |
Step 3 4-Bromo-2-(hydroxymethyl)phenol: A solution of 5-bromo-2-hydroxybenzoic acid (21.7 g; 100 mmol; 1.00 equiv) in tetrahydrofuran (200 mL) was added to a suspension of lithium aluminum hydride (5.7 g; 150 mmol; 1.50 equiv) in tetrahydrofuran (100 mL). The suspension was virgously stirred for about 16 hours at ambient temperature and then quenched by adding 3M hydrochloric acid (300 mL). Following standard extractive workup with ethyl acetate, the crude residue was re-crystallized from ethyl acetate/hexane (1/10) to give the title product as gray solid (12.4 g; 60percent yield). 1H NMR (400 MHz, CDCl3) 6: 9.68 (s, 1H), 7.39 (s, 1H), 7.19 (dd, J=2.0, 2.0 Hz, 1H), 6.72 (d, J=8.4 Hz, 1H), 5.10 (s, 1H), 4.44 (s, 2H). |
[ 170434-11-4 ]
5-Bromo-2-(hydroxymethyl)phenol
Similarity: 0.97
[ 170434-11-4 ]
5-Bromo-2-(hydroxymethyl)phenol
Similarity: 0.97
[ 170434-11-4 ]
5-Bromo-2-(hydroxymethyl)phenol
Similarity: 0.97
[ 17102-63-5 ]
4-Bromo-2-methoxybenzyl alcohol
Similarity: 0.88
[ 29922-56-3 ]
2-Bromo-4-(hydroxymethyl)phenol
Similarity: 0.86
[ 2737-19-1 ]
2-Bromo-5-(hydroxymethyl)phenol
Similarity: 0.86
[ 666747-04-2 ]
3-Bromo-4-(hydroxymethyl)phenol
Similarity: 0.84